-
-
Most of us dread the chief complaint of weakness. This nonspecific symptom engenders a differential that ranges from malingering to fatal, from psychiatric to cancer. The finding of demonstrable muscle weakness helps, but then leads to a confusing set of relatively rare diagnoses.
-
A new generation of physicians is reinvigorating the field of cardiac arrest research. I am grateful that two of the experts in this area have written this issue of EM Reports. After reading this, I anticipate you will place these principles into practice.
-
-
-
-
With advances in medical science, patients with serious congenital diseases are living into adulthood. Where once cystic fibrosis patients died in infancy, patients now live into their 40s. Although many of the standard treatments for COPD apply to cystic fibrosis, there are specific differences in management, which this monograph highlights.
-
-
Imagine this e-mail from one of your colleagues being Exhibit A at your malpractice trial: "You misdiagnosed Jane Doe with indigestion last night and she showed up this morning on my shift with a heart attack and didn't live. Since this is your third time to miss this sort of thing, you really need to pay better attention."
-
Before giving a stroke patient tissue plasminogen activator (tPA), you must consider not only whether the patent is a candidate, but also whether the setting is appropriate, says Edward Jauch, MD, MS, assistant professor in the department of emergency medicine at University of Cincinnati and a member of the Greater Cincinnati/Northern Kentucky Stroke Team.